Roche acquires Danish pharmaceutical company Santaris Pharma for USD 450 million
Last Update: 2014-08-06
Search more information of high quality chemicals, good prices and reliable suppliers, visit
Source: great wisdom astak news agency announced on Monday that Roche will spend no more than 450 million US dollars to acquire santaris Pharma, a Danish biomedical enterprise
According to the agreement signed by both parties, Roche will pay 250 million US dollars in advance and 200 million US dollars in the balance after the products reach the expected target
The acquisition is expected to be completed in August this year
Santaris Pharma is a Danish biopharmaceutical company founded in 2003
It mainly uses the unique LND platform and tissue targeting technology to develop antisense gene products
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to firstname.lastname@example.org
. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.